Bio-Rad Labs rises on upbeat Q4 profit

Bio-Rad Laboratories

16/02/2024 16:09

** Shares of diagnostic firm Bio-Rad Laboratories  BIO.N 
rise 9.95% to $361.45  
    ** Co reported Q4 profit that beat estimates, helped by a
better-than-expected demand for its diagnostic instruments and
quality control products  
    ** Reported adj. profit of $3.1 per share above analysts'
estimates of $2.82
     ** BIO sees adj. revenue growth between 1.0% to 2.5% on a
currency-neutral basis for 2024
    ** The company said it is cautiously optimistic about the
gradual recovery of the biopharma sector in the second half of
the year.
    ** Stock has fallen 27.9% in the last 12 months 
    

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))